What GPs need to know about the introduction of primary HPV testing in cervical screening
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.
Deciding how best to roll out HPV testing as the primary cervical screening test
Evidence shows that human papillomavirus (HPV) testing is a better way of identifying women at risk of cervical cancer than the cytology (smear) test that examines cells under a microscope.
NHS Cervical Screening Programme approves new HPV tests and issues guidance for laboratories
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.
International delegates told of HPV primary screening rollout challenges
PHE screening team members and clinicians attended the 40th European Congress of Cytology in Liverpool.